Novel motif:104: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:05, 9 September 2013
name: | motif104_GTWSGMT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006481 | C-terminal protein methylation | 4.821052e-11 |
GO:0034623 | cellular macromolecular complex disassembly | 1.669208e-10 |
GO:0043624 | cellular protein complex disassembly | 2.563193e-10 |
GO:0032984 | macromolecular complex disassembly | 3.643667e-10 |
GO:0007610 | behavior | 4.419740e-10 |
GO:0043241 | protein complex disassembly | 6.316580e-10 |
GO:0006415 | translational termination | 1.949691e-9 |
GO:0007612 | learning | 5.513619e-9 |
GO:0007611 | learning or memory | 1.333687e-8 |
GO:0050890 | cognition | 2.048188e-8 |
GO:0003017 | lymph circulation | 6.066136e-8 |
GO:0002769 | natural killer cell inhibitory signaling pathway | 2.129151e-7 |
GO:0000278 | mitotic cell cycle | 2.246796e-7 |
GO:0045767 | regulation of anti-apoptosis | 3.234611e-7 |
GO:0060078 | regulation of postsynaptic membrane potential | 4.573999e-7 |
GO:0035330 | regulation of hippo signaling cascade | 5.955966e-7 |
GO:0042178 | xenobiotic catabolic process | 6.581443e-7 |
GO:0019083 | viral transcription | 6.788269e-7 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 9.312748e-7 |
GO:0045768 | positive regulation of anti-apoptosis | 1.244751e-6 |
GO:0045666 | positive regulation of neuron differentiation | 1.529959e-6 |
GO:0010713 | negative regulation of collagen metabolic process | 1.884116e-6 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 1.926604e-6 |
GO:0032966 | negative regulation of collagen biosynthetic process | 2.054277e-6 |
GO:0060080 | regulation of inhibitory postsynaptic membrane potential | 2.350666e-6 |
GO:0051329 | interphase of mitotic cell cycle | 2.391798e-6 |
GO:0045007 | depurination | 2.642654e-6 |
GO:0008306 | associative learning | 3.461592e-6 |
GO:0072033 | renal vesicle formation | 3.484507e-6 |
GO:0043312 | neutrophil degranulation | 4.125139e-6 |
GO:0031018 | endocrine pancreas development | 4.167468e-6 |
GO:0035270 | endocrine system development | 4.730839e-6 |
GO:0051325 | interphase | 4.762999e-6 |
GO:0060074 | synapse maturation | 6.806141e-6 |
GO:0006955 | immune response | 7.634640e-6 |
GO:0006449 | regulation of translational termination | 7.944784e-6 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 9.556345e-6 |
GO:0007626 | locomotory behavior | 1.070212e-5 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.122987e-5 |
GO:0030534 | adult behavior | 1.326354e-5 |
GO:0045190 | isotype switching | 1.379764e-5 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.404187e-5 |
GO:0051971 | positive regulation of transmission of nerve impulse | 1.463686e-5 |
GO:0071845 | cellular component disassembly at cellular level | 1.466477e-5 |
GO:0051224 | negative regulation of protein transport | 1.632866e-5 |
GO:0060081 | membrane hyperpolarization | 1.794224e-5 |
GO:0051351 | positive regulation of ligase activity | 1.903996e-5 |
GO:0022411 | cellular component disassembly | 1.942245e-5 |
GO:0030900 | forebrain development | 2.120600e-5 |
GO:0072092 | ureteric bud invasion | 2.261798e-5 |
GO:0019058 | viral infectious cycle | 2.959410e-5 |
GO:0031646 | positive regulation of neurological system process | 2.992607e-5 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 3.021035e-5 |
GO:0035264 | multicellular organism growth | 3.123052e-5 |
GO:0008344 | adult locomotory behavior | 3.245083e-5 |
GO:0015949 | nucleobase-containing small molecule interconversion | 3.453969e-5 |
GO:0006952 | defense response | 3.692436e-5 |
GO:0045664 | regulation of neuron differentiation | 3.702568e-5 |
GO:0050806 | positive regulation of synaptic transmission | 3.811291e-5 |
GO:0043254 | regulation of protein complex assembly | 4.254402e-5 |
GO:0016032 | viral reproduction | 4.727404e-5 |
GO:0051340 | regulation of ligase activity | 4.730798e-5 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.913643e-5 |
GO:0072093 | metanephric renal vesicle formation | 4.913925e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 4.966314e-5 |
GO:0060079 | regulation of excitatory postsynaptic membrane potential | 5.001383e-5 |
GO:0048169 | regulation of long-term neuronal synaptic plasticity | 5.895422e-5 |
GO:0061386 | closure of optic fissure | 6.101720e-5 |
GO:0035332 | positive regulation of hippo signaling cascade | 6.101720e-5 |
GO:0016137 | glycoside metabolic process | 6.128397e-5 |
GO:0021553 | olfactory nerve development | 6.207802e-5 |
GO:0035752 | lysosomal lumen pH elevation | 6.352086e-5 |
GO:0001575 | globoside metabolic process | 6.352086e-5 |
GO:0000046 | autophagic vacuole fusion | 6.352086e-5 |
GO:0043039 | tRNA aminoacylation | 6.562157e-5 |
GO:0007093 | mitotic cell cycle checkpoint | 6.588573e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 6.630657e-5 |
GO:0050902 | leukocyte adhesive activation | 6.630657e-5 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 7.006261e-5 |
GO:0002765 | immune response-inhibiting signal transduction | 7.065355e-5 |
GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response | 7.102966e-5 |
GO:0060479 | lung cell differentiation | 7.200432e-5 |
GO:0051170 | nuclear import | 7.646054e-5 |
GO:0006434 | seryl-tRNA aminoacylation | 8.066217e-5 |
GO:0051262 | protein tetramerization | 8.482311e-5 |
GO:0006606 | protein import into nucleus | 8.985936e-5 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 9.982774e-5 |
GO:0006959 | humoral immune response | 1.049313e-4 |
GO:0032929 | negative regulation of superoxide anion generation | 1.063805e-4 |
GO:0042391 | regulation of membrane potential | 1.075938e-4 |
GO:0051320 | S phase | 1.110104e-4 |
GO:0051453 | regulation of intracellular pH | 1.142175e-4 |
GO:0090317 | negative regulation of intracellular protein transport | 1.147743e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 1.190042e-4 |
GO:0000084 | S phase of mitotic cell cycle | 1.247869e-4 |
GO:0032271 | regulation of protein polymerization | 1.249810e-4 |
GO:0030832 | regulation of actin filament length | 1.290170e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.295508e-4 |
GO:0034660 | ncRNA metabolic process | 1.382351e-4 |
GO:0016071 | mRNA metabolic process | 1.435909e-4 |
GO:0034126 | positive regulation of MyD88-dependent toll-like receptor signaling pathway | 1.446594e-4 |
GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway | 1.446594e-4 |
GO:0006148 | inosine catabolic process | 1.446594e-4 |
GO:0006738 | nicotinamide riboside catabolic process | 1.446594e-4 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 1.446594e-4 |
GO:0050767 | regulation of neurogenesis | 1.469436e-4 |
GO:0051452 | intracellular pH reduction | 1.472388e-4 |
GO:0003382 | epithelial cell morphogenesis | 1.494654e-4 |
GO:0016139 | glycoside catabolic process | 1.535456e-4 |
GO:0048246 | macrophage chemotaxis | 1.585904e-4 |
GO:0002339 | B cell selection | 1.621699e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.625565e-4 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.667453e-4 |
GO:0007417 | central nervous system development | 1.690473e-4 |
GO:0060677 | ureteric bud elongation | 1.701143e-4 |
GO:0006563 | L-serine metabolic process | 1.814156e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.822301e-4 |
GO:0016242 | negative regulation of macroautophagy | 1.832972e-4 |
GO:0051899 | membrane depolarization | 1.839151e-4 |
GO:0006565 | L-serine catabolic process | 1.857831e-4 |
GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein | 1.860093e-4 |
GO:0006414 | translational elongation | 1.939820e-4 |
GO:0015780 | nucleotide-sugar transport | 1.945449e-4 |
GO:0002149 | hypochlorous acid biosynthetic process | 1.946776e-4 |
GO:0000075 | cell cycle checkpoint | 1.965343e-4 |
GO:0043587 | tongue morphogenesis | 2.103756e-4 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.119430e-4 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 2.134110e-4 |
GO:0042559 | pteridine-containing compound biosynthetic process | 2.141269e-4 |
GO:0007270 | neuron-neuron synaptic transmission | 2.220088e-4 |
GO:0030641 | regulation of cellular pH | 2.258208e-4 |
GO:0045087 | innate immune response | 2.478610e-4 |
GO:0043243 | positive regulation of protein complex disassembly | 2.566744e-4 |
GO:0016241 | regulation of macroautophagy | 2.651059e-4 |
GO:0009313 | oligosaccharide catabolic process | 2.794378e-4 |
GO:0006258 | UDP-glucose catabolic process | 2.860430e-4 |
GO:0002344 | B cell affinity maturation | 2.878977e-4 |
GO:0042942 | D-serine transport | 2.878977e-4 |
GO:0035802 | adrenal cortex formation | 3.103720e-4 |
GO:0034509 | centromeric core chromatin assembly | 3.138083e-4 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 3.140201e-4 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.172575e-4 |
GO:0030833 | regulation of actin filament polymerization | 3.242774e-4 |
GO:0042990 | regulation of transcription factor import into nucleus | 3.252898e-4 |
GO:0051648 | vesicle localization | 3.255903e-4 |
GO:0060022 | hard palate development | 3.348278e-4 |
GO:0008064 | regulation of actin polymerization or depolymerization | 3.462823e-4 |
GO:0048713 | regulation of oligodendrocyte differentiation | 3.499709e-4 |
GO:0042940 | D-amino acid transport | 3.551168e-4 |
GO:0006364 | rRNA processing | 3.579195e-4 |
GO:0042339 | keratan sulfate metabolic process | 3.691414e-4 |
GO:0051289 | protein homotetramerization | 3.702227e-4 |
GO:0042891 | antibiotic transport | 3.984840e-4 |
GO:0006448 | regulation of translational elongation | 4.018668e-4 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 4.104250e-4 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 4.104250e-4 |
GO:0006518 | peptide metabolic process | 4.202741e-4 |
GO:0045851 | pH reduction | 4.207385e-4 |
GO:0015810 | aspartate transport | 4.304665e-4 |
GO:0051454 | intracellular pH elevation | 4.341397e-4 |
GO:0031016 | pancreas development | 4.387142e-4 |
GO:0042493 | response to drug | 4.515704e-4 |
GO:0048683 | regulation of collateral sprouting of intact axon in response to injury | 4.523801e-4 |
GO:0006605 | protein targeting | 4.560200e-4 |
GO:0032535 | regulation of cellular component size | 4.560465e-4 |
GO:0017148 | negative regulation of translation | 4.676060e-4 |
GO:0072384 | organelle transport along microtubule | 4.847735e-4 |
GO:0042308 | negative regulation of protein import into nucleus | 4.973640e-4 |
GO:0002200 | somatic diversification of immune receptors | 5.034018e-4 |
GO:0032764 | negative regulation of mast cell cytokine production | 5.095040e-4 |
GO:0009069 | serine family amino acid metabolic process | 5.108657e-4 |
GO:0048538 | thymus development | 5.265290e-4 |
GO:0047496 | vesicle transport along microtubule | 5.270177e-4 |
GO:0071918 | urea transmembrane transport | 5.374966e-4 |
GO:0033157 | regulation of intracellular protein transport | 5.535990e-4 |
GO:0007035 | vacuolar acidification | 5.733949e-4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 5.743031e-4 |
GO:0032387 | negative regulation of intracellular transport | 6.013608e-4 |
GO:0071779 | G1/S transition checkpoint | 6.068895e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 6.087522e-4 |
GO:0006418 | tRNA aminoacylation for protein translation | 6.104003e-4 |
GO:0019438 | aromatic compound biosynthetic process | 6.118510e-4 |
GO:0014823 | response to activity | 6.213028e-4 |
GO:0070926 | regulation of ATP:ADP antiporter activity | 6.324049e-4 |
GO:0050710 | negative regulation of cytokine secretion | 6.378628e-4 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.388449e-4 |
GO:0009062 | fatty acid catabolic process | 6.519946e-4 |
GO:0016072 | rRNA metabolic process | 6.816510e-4 |
GO:0060555 | induction of necroptosis by extracellular signals | 6.885937e-4 |
GO:0042306 | regulation of protein import into nucleus | 7.087950e-4 |
GO:0006412 | translation | 7.102061e-4 |
GO:0043101 | purine-containing compound salvage | 7.435160e-4 |
GO:0021509 | roof plate formation | 7.526972e-4 |
GO:0042742 | defense response to bacterium | 7.760610e-4 |
GO:0060487 | lung epithelial cell differentiation | 7.870756e-4 |
GO:0030521 | androgen receptor signaling pathway | 7.959510e-4 |
GO:0007597 | blood coagulation, intrinsic pathway | 7.966298e-4 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 8.036253e-4 |
GO:0014009 | glial cell proliferation | 8.056621e-4 |
GO:0015813 | L-glutamate transport | 8.184757e-4 |
GO:0070683 | mitotic cell cycle G2/M transition decatenation checkpoint | 8.238623e-4 |
GO:0022403 | cell cycle phase | 8.485974e-4 |
GO:0009308 | amine metabolic process | 8.717988e-4 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 8.947408e-4 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 9.078937e-4 |
GO:0048205 | COPI coating of Golgi vesicle | 9.208337e-4 |
GO:0010332 | response to gamma radiation | 9.644381e-4 |
GO:0007346 | regulation of mitotic cell cycle | 9.692317e-4 |
GO:0022415 | viral reproductive process | 9.707939e-4 |
GO:0007268 | synaptic transmission | 9.984149e-4 |
GO:0002218 | activation of innate immune response | 1.015264e-3 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 1.016042e-3 |
GO:0007525 | somatic muscle development | 1.031808e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 1.057063e-3 |
GO:0034201 | response to oleic acid | 1.058487e-3 |
GO:0035425 | autocrine signaling | 1.077505e-3 |
GO:0007420 | brain development | 1.104605e-3 |
GO:0033153 | T cell receptor V(D)J recombination | 1.113544e-3 |
GO:0045616 | regulation of keratinocyte differentiation | 1.143651e-3 |
GO:0051403 | stress-activated MAPK cascade | 1.151661e-3 |
GO:0060428 | lung epithelium development | 1.189837e-3 |
GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 1.191268e-3 |
GO:0045343 | regulation of MHC class I biosynthetic process | 1.198616e-3 |
GO:0034097 | response to cytokine stimulus | 1.204761e-3 |
GO:0002679 | respiratory burst involved in defense response | 1.205947e-3 |
GO:0000060 | protein import into nucleus, translocation | 1.208786e-3 |
GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein | 1.208786e-3 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 1.215752e-3 |
GO:0072087 | renal vesicle development | 1.227912e-3 |
GO:0003338 | metanephros morphogenesis | 1.228989e-3 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 1.228989e-3 |
GO:0072526 | pyridine-containing compound catabolic process | 1.232060e-3 |
GO:0051650 | establishment of vesicle localization | 1.232826e-3 |
GO:0021537 | telencephalon development | 1.240921e-3 |
GO:0008063 | Toll signaling pathway | 1.242510e-3 |
GO:0002376 | immune system process | 1.260570e-3 |
GO:0014048 | regulation of glutamate secretion | 1.280582e-3 |
GO:0002384 | hepatic immune response | 1.285873e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 1.287246e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.289572e-3 |
GO:0072283 | metanephric renal vesicle morphogenesis | 1.313203e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 1.313292e-3 |
GO:0015820 | leucine transport | 1.313292e-3 |
GO:0005993 | trehalose catabolic process | 1.351351e-3 |
GO:0072273 | metanephric nephron morphogenesis | 1.353148e-3 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.370853e-3 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.388133e-3 |
GO:0061032 | visceral serous pericardium development | 1.388574e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.388574e-3 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 1.388574e-3 |
GO:0035635 | entry of bacterium into host cell | 1.388574e-3 |
GO:0030862 | positive regulation of polarized epithelial cell differentiation | 1.388574e-3 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 1.409080e-3 |
GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 1.422832e-3 |
GO:0051248 | negative regulation of protein metabolic process | 1.423391e-3 |
GO:0071156 | regulation of cell cycle arrest | 1.429696e-3 |
GO:0031397 | negative regulation of protein ubiquitination | 1.430550e-3 |
GO:0034374 | low-density lipoprotein particle remodeling | 1.433312e-3 |
GO:0034383 | low-density lipoprotein particle clearance | 1.454859e-3 |
GO:0048678 | response to axon injury | 1.492020e-3 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 1.497192e-3 |
GO:0048513 | organ development | 1.508397e-3 |
GO:0043043 | peptide biosynthetic process | 1.568382e-3 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 1.576970e-3 |
GO:0044057 | regulation of system process | 1.589523e-3 |
GO:0046326 | positive regulation of glucose import | 1.620451e-3 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.623346e-3 |
GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 1.645558e-3 |
GO:0072077 | renal vesicle morphogenesis | 1.651262e-3 |
GO:0060049 | regulation of protein glycosylation | 1.662876e-3 |
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 1.678260e-3 |
GO:0007568 | aging | 1.680213e-3 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 1.680811e-3 |
GO:0017038 | protein import | 1.692319e-3 |
GO:0007527 | adult somatic muscle development | 1.722941e-3 |
GO:0061303 | cornea development in camera-type eye | 1.745752e-3 |
GO:0048194 | Golgi vesicle budding | 1.820918e-3 |
GO:0021778 | oligodendrocyte cell fate specification | 1.820918e-3 |
GO:0031557 | induction of programmed cell death in response to chemical stimulus | 1.820918e-3 |
GO:0072329 | monocarboxylic acid catabolic process | 1.831817e-3 |
GO:0003281 | ventricular septum development | 1.852772e-3 |
GO:0051967 | negative regulation of synaptic transmission, glutamatergic | 1.852973e-3 |
GO:0007632 | visual behavior | 1.854386e-3 |
GO:0006903 | vesicle targeting | 1.890578e-3 |
GO:0033211 | adiponectin-mediated signaling pathway | 1.924990e-3 |
GO:0006520 | cellular amino acid metabolic process | 1.938548e-3 |
GO:0045076 | regulation of interleukin-2 biosynthetic process | 1.982246e-3 |
GO:0030316 | osteoclast differentiation | 1.997958e-3 |
GO:0007267 | cell-cell signaling | 2.020206e-3 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 2.029880e-3 |
GO:0030212 | hyaluronan metabolic process | 2.029880e-3 |
GO:0045870 | positive regulation of retroviral genome replication | 2.034433e-3 |
GO:0046168 | glycerol-3-phosphate catabolic process | 2.034433e-3 |
GO:0051223 | regulation of protein transport | 2.043919e-3 |
GO:0015800 | acidic amino acid transport | 2.079182e-3 |
GO:0043414 | macromolecule methylation | 2.088696e-3 |
GO:0072166 | posterior mesonephric tubule development | 2.091912e-3 |
GO:0006749 | glutathione metabolic process | 2.108205e-3 |
GO:0014049 | positive regulation of glutamate secretion | 2.110413e-3 |
GO:0001956 | positive regulation of neurotransmitter secretion | 2.151880e-3 |
GO:0001781 | neutrophil apoptosis | 2.158536e-3 |
GO:0071379 | cellular response to prostaglandin stimulus | 2.166044e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 2.178935e-3 |
GO:0021510 | spinal cord development | 2.186724e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 2.190555e-3 |
GO:0090174 | organelle membrane fusion | 2.217181e-3 |
GO:0055070 | copper ion homeostasis | 2.229882e-3 |
GO:0031349 | positive regulation of defense response | 2.276744e-3 |
GO:0045901 | positive regulation of translational elongation | 2.361132e-3 |
GO:0045905 | positive regulation of translational termination | 2.361132e-3 |
GO:0006452 | translational frameshifting | 2.361132e-3 |
GO:0006298 | mismatch repair | 2.398803e-3 |
GO:0043990 | histone H2A-S1 phosphorylation | 2.440463e-3 |
GO:0042938 | dipeptide transport | 2.440463e-3 |
GO:0051960 | regulation of nervous system development | 2.446771e-3 |
GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation | 2.481804e-3 |
GO:0010828 | positive regulation of glucose transport | 2.500607e-3 |
GO:0050769 | positive regulation of neurogenesis | 2.503336e-3 |
GO:0016064 | immunoglobulin mediated immune response | 2.509130e-3 |
GO:0045445 | myoblast differentiation | 2.513635e-3 |
GO:0018199 | peptidyl-glutamine modification | 2.566283e-3 |
GO:0000090 | mitotic anaphase | 2.566283e-3 |
GO:0022612 | gland morphogenesis | 2.596501e-3 |
GO:0006913 | nucleocytoplasmic transport | 2.629040e-3 |
GO:0051591 | response to cAMP | 2.642801e-3 |
GO:0032836 | glomerular basement membrane development | 2.647073e-3 |
GO:0006886 | intracellular protein transport | 2.673535e-3 |
GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development | 2.735557e-3 |
GO:0032386 | regulation of intracellular transport | 2.778553e-3 |
GO:0045004 | DNA replication proofreading | 2.826949e-3 |
GO:0070165 | positive regulation of adiponectin secretion | 2.826949e-3 |
GO:0033031 | positive regulation of neutrophil apoptosis | 2.826949e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 2.841798e-3 |
GO:0060040 | retinal bipolar neuron differentiation | 2.852594e-3 |
GO:0060563 | neuroepithelial cell differentiation | 2.910755e-3 |
GO:0072028 | nephron morphogenesis | 2.917202e-3 |
GO:0044130 | negative regulation of growth of symbiont in host | 2.953657e-3 |
GO:0007585 | respiratory gaseous exchange | 2.992152e-3 |
GO:0006399 | tRNA metabolic process | 2.996448e-3 |
GO:0070544 | histone H3-K36 demethylation | 3.016368e-3 |
GO:0048679 | regulation of axon regeneration | 3.068510e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 3.069695e-3 |
GO:0034138 | toll-like receptor 3 signaling pathway | 3.141236e-3 |
GO:0046395 | carboxylic acid catabolic process | 3.209302e-3 |
GO:0044106 | cellular amine metabolic process | 3.260709e-3 |
GO:0007215 | glutamate signaling pathway | 3.326941e-3 |
GO:0009071 | serine family amino acid catabolic process | 3.339986e-3 |
GO:0090066 | regulation of anatomical structure size | 3.359130e-3 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 3.370624e-3 |
GO:0042340 | keratan sulfate catabolic process | 3.382714e-3 |
GO:0003357 | noradrenergic neuron differentiation | 3.387921e-3 |
GO:0051622 | negative regulation of norepinephrine uptake | 3.400288e-3 |
GO:0070495 | negative regulation of thrombin receptor signaling pathway | 3.400288e-3 |
GO:0051585 | negative regulation of dopamine uptake | 3.400288e-3 |
GO:0050812 | regulation of acyl-CoA biosynthetic process | 3.400288e-3 |
GO:0042159 | lipoprotein catabolic process | 3.409214e-3 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 3.412631e-3 |
GO:0006807 | nitrogen compound metabolic process | 3.416903e-3 |
GO:0001832 | blastocyst growth | 3.425729e-3 |
GO:0050709 | negative regulation of protein secretion | 3.431394e-3 |
GO:0002328 | pro-B cell differentiation | 3.479733e-3 |
GO:0002034 | regulation of blood vessel size by renin-angiotensin | 3.514066e-3 |
GO:0030317 | sperm motility | 3.541628e-3 |
GO:0019226 | transmission of nerve impulse | 3.589125e-3 |
GO:0006013 | mannose metabolic process | 3.605218e-3 |
GO:0002091 | negative regulation of receptor internalization | 3.626120e-3 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 3.626369e-3 |
GO:0050877 | neurological system process | 3.635011e-3 |
GO:0045540 | regulation of cholesterol biosynthetic process | 3.661259e-3 |
GO:0045089 | positive regulation of innate immune response | 3.666143e-3 |
GO:0043086 | negative regulation of catalytic activity | 3.714477e-3 |
GO:0030855 | epithelial cell differentiation | 3.777583e-3 |
GO:0045605 | negative regulation of epidermal cell differentiation | 3.783847e-3 |
GO:0006805 | xenobiotic metabolic process | 3.821212e-3 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.858336e-3 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 3.887901e-3 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 3.911066e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 3.959914e-3 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 4.017028e-3 |
GO:0006873 | cellular ion homeostasis | 4.018058e-3 |
GO:0072376 | protein activation cascade | 4.023216e-3 |
GO:0010507 | negative regulation of autophagy | 4.046275e-3 |
GO:0051983 | regulation of chromosome segregation | 4.051791e-3 |
GO:0003056 | regulation of vascular smooth muscle contraction | 4.150114e-3 |
GO:0051169 | nuclear transport | 4.166059e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 4.167520e-3 |
GO:0060674 | placenta blood vessel development | 4.408838e-3 |
GO:0032663 | regulation of interleukin-2 production | 4.476018e-3 |
GO:0071786 | endoplasmic reticulum tubular network organization | 4.546171e-3 |
GO:0032329 | serine transport | 4.546171e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 4.559147e-3 |
GO:0060087 | relaxation of vascular smooth muscle | 4.580202e-3 |
GO:0007275 | multicellular organismal development | 4.580547e-3 |
GO:0033555 | multicellular organismal response to stress | 4.616275e-3 |
GO:0070201 | regulation of establishment of protein localization | 4.642827e-3 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 4.646616e-3 |
GO:0034142 | toll-like receptor 4 signaling pathway | 4.655669e-3 |
GO:0006635 | fatty acid beta-oxidation | 4.678603e-3 |
GO:0043490 | malate-aspartate shuttle | 4.699591e-3 |
GO:0006436 | tryptophanyl-tRNA aminoacylation | 4.699591e-3 |
GO:0042254 | ribosome biogenesis | 4.715715e-3 |
GO:0080134 | regulation of response to stress | 4.732682e-3 |
GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 4.772217e-3 |
GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway | 4.786320e-3 |
GO:0044245 | polysaccharide digestion | 4.786320e-3 |
GO:0048285 | organelle fission | 4.841439e-3 |
GO:0000305 | response to oxygen radical | 4.881154e-3 |
GO:0071569 | protein ufmylation | 4.896872e-3 |
GO:0009791 | post-embryonic development | 4.906643e-3 |
GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation | 4.910396e-3 |
GO:0001508 | regulation of action potential | 4.939483e-3 |
GO:0051176 | positive regulation of sulfur metabolic process | 4.950973e-3 |
GO:0043988 | histone H3-S28 phosphorylation | 4.964318e-3 |
GO:0043987 | histone H3-S10 phosphorylation | 4.964318e-3 |
GO:0002064 | epithelial cell development | 4.971685e-3 |
GO:0055082 | cellular chemical homeostasis | 5.020463e-3 |
GO:0044092 | negative regulation of molecular function | 5.043622e-3 |
GO:0001824 | blastocyst development | 5.083210e-3 |
GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway | 5.089718e-3 |
GO:0006885 | regulation of pH | 5.144433e-3 |
GO:0051322 | anaphase | 5.170779e-3 |
GO:0051640 | organelle localization | 5.197318e-3 |
GO:0034504 | protein localization to nucleus | 5.252149e-3 |
GO:0090181 | regulation of cholesterol metabolic process | 5.290325e-3 |
GO:0042129 | regulation of T cell proliferation | 5.347828e-3 |
GO:0022414 | reproductive process | 5.393915e-3 |
GO:0043149 | stress fiber assembly | 5.473114e-3 |
GO:0001963 | synaptic transmission, dopaminergic | 5.473114e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 5.495468e-3 |
GO:0030595 | leukocyte chemotaxis | 5.498290e-3 |
GO:0051656 | establishment of organelle localization | 5.532068e-3 |
GO:0051235 | maintenance of location | 5.599303e-3 |
GO:0009887 | organ morphogenesis | 5.615839e-3 |
GO:0034134 | toll-like receptor 2 signaling pathway | 5.754207e-3 |
GO:0034130 | toll-like receptor 1 signaling pathway | 5.754207e-3 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 5.762462e-3 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 5.818853e-3 |
GO:0045086 | positive regulation of interleukin-2 biosynthetic process | 5.820170e-3 |
GO:0043244 | regulation of protein complex disassembly | 5.835322e-3 |
GO:0034720 | histone H3-K4 demethylation | 5.845981e-3 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 5.924446e-3 |
GO:0045629 | negative regulation of T-helper 2 cell differentiation | 5.927240e-3 |
GO:0019858 | cytosine metabolic process | 5.937039e-3 |
GO:0000003 | reproduction | 5.967283e-3 |
GO:0007067 | mitosis | 6.008293e-3 |
GO:0030325 | adrenal gland development | 6.028075e-3 |
GO:0035112 | genitalia morphogenesis | 6.028148e-3 |
GO:0006516 | glycoprotein catabolic process | 6.086641e-3 |
GO:0021773 | striatal medium spiny neuron differentiation | 6.086742e-3 |
GO:0046591 | embryonic leg joint morphogenesis | 6.086742e-3 |
GO:0071956 | cellular component maintenance at cellular level | 6.113947e-3 |
GO:0071466 | cellular response to xenobiotic stimulus | 6.132487e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 6.212754e-3 |
GO:0031644 | regulation of neurological system process | 6.265178e-3 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 6.265751e-3 |
GO:0014070 | response to organic cyclic compound | 6.393305e-3 |
GO:0042762 | regulation of sulfur metabolic process | 6.439223e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.532915e-3 |
GO:0071158 | positive regulation of cell cycle arrest | 6.557639e-3 |
GO:0034763 | negative regulation of transmembrane transport | 6.557639e-3 |
GO:0090192 | regulation of glomerulus development | 6.573185e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 6.624222e-3 |
GO:0045986 | negative regulation of smooth muscle contraction | 6.624222e-3 |
GO:0035021 | negative regulation of Rac protein signal transduction | 6.661577e-3 |
GO:0045604 | regulation of epidermal cell differentiation | 6.726473e-3 |
GO:0006998 | nuclear envelope organization | 6.729812e-3 |
GO:0051384 | response to glucocorticoid stimulus | 6.733220e-3 |
GO:0010616 | negative regulation of cardiac muscle adaptation | 6.776006e-3 |
GO:0006878 | cellular copper ion homeostasis | 6.828496e-3 |
GO:0050808 | synapse organization | 6.845420e-3 |
GO:0061047 | positive regulation of branching involved in lung morphogenesis | 6.868303e-3 |
GO:0009410 | response to xenobiotic stimulus | 6.879344e-3 |
GO:0010886 | positive regulation of cholesterol storage | 6.887232e-3 |
GO:0033566 | gamma-tubulin complex localization | 6.936624e-3 |
GO:0072334 | UDP-galactose transmembrane transport | 6.936624e-3 |
GO:0046146 | tetrahydrobiopterin metabolic process | 7.008265e-3 |
GO:0002829 | negative regulation of type 2 immune response | 7.008265e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 7.045156e-3 |
GO:0002446 | neutrophil mediated immunity | 7.082933e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 7.164568e-3 |
GO:0072210 | metanephric nephron development | 7.259408e-3 |
GO:0031347 | regulation of defense response | 7.262091e-3 |
GO:0048771 | tissue remodeling | 7.332795e-3 |
GO:0043524 | negative regulation of neuron apoptosis | 7.349602e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 7.355837e-3 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 7.391802e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 7.482510e-3 |
GO:0043129 | surfactant homeostasis | 7.548914e-3 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 7.691456e-3 |
GO:0001818 | negative regulation of cytokine production | 7.696902e-3 |
GO:0009083 | branched chain family amino acid catabolic process | 7.705425e-3 |
GO:0034219 | carbohydrate transmembrane transport | 7.706071e-3 |
GO:0030010 | establishment of cell polarity | 7.708262e-3 |
GO:0050707 | regulation of cytokine secretion | 7.730101e-3 |
GO:0001302 | replicative cell aging | 7.747107e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 7.777362e-3 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 7.777362e-3 |
GO:0006954 | inflammatory response | 7.872544e-3 |
GO:0044273 | sulfur compound catabolic process | 7.873022e-3 |
GO:0071173 | spindle assembly checkpoint | 7.884068e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.614908e-11 |
GO:0045796 | negative regulation of intestinal cholesterol absorption | 1.637677e-11 |
GO:0010949 | negative regulation of intestinal phytosterol absorption | 1.637677e-11 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.825709e-10 |
GO:0046031 | ADP metabolic process | 2.356413e-10 |
GO:0046709 | IDP catabolic process | 5.606765e-10 |
GO:0046032 | ADP catabolic process | 5.606765e-10 |
GO:0060457 | negative regulation of digestive system process | 1.350375e-9 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.066350e-8 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.485487e-8 |
GO:0051272 | positive regulation of cellular component movement | 1.888711e-8 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 2.449041e-8 |
GO:2000147 | positive regulation of cell motility | 5.617837e-8 |
GO:0040017 | positive regulation of locomotion | 7.956836e-8 |
GO:0051591 | response to cAMP | 1.152410e-7 |
GO:0030335 | positive regulation of cell migration | 1.592843e-7 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.817037e-7 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 6.186279e-7 |
GO:0032057 | negative regulation of translational initiation in response to stress | 1.142505e-6 |
GO:0009134 | nucleoside diphosphate catabolic process | 1.457604e-6 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.988398e-6 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 2.202866e-6 |
GO:0051182 | coenzyme transport | 2.329942e-6 |
GO:0046452 | dihydrofolate metabolic process | 2.749801e-6 |
GO:0060048 | cardiac muscle contraction | 4.819899e-6 |
GO:0001579 | medium-chain fatty acid transport | 5.185084e-6 |
GO:0051270 | regulation of cellular component movement | 7.981528e-6 |
GO:0032055 | negative regulation of translation in response to stress | 1.145430e-5 |
GO:0008033 | tRNA processing | 1.261668e-5 |
GO:0030240 | skeletal muscle thin filament assembly | 1.702697e-5 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 1.914825e-5 |
GO:0032606 | type I interferon production | 2.143649e-5 |
GO:0045329 | carnitine biosynthetic process | 2.729210e-5 |
GO:2000145 | regulation of cell motility | 2.829197e-5 |
GO:0046700 | heterocycle catabolic process | 3.404544e-5 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 3.544287e-5 |
GO:0051932 | synaptic transmission, GABAergic | 3.560659e-5 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 4.316239e-5 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 4.365274e-5 |
GO:0051567 | histone H3-K9 methylation | 4.794164e-5 |
GO:0006666 | 3-keto-sphinganine metabolic process | 5.055991e-5 |
GO:0030334 | regulation of cell migration | 5.640297e-5 |
GO:0034470 | ncRNA processing | 5.855585e-5 |
GO:0014866 | skeletal myofibril assembly | 6.120025e-5 |
GO:0043154 | negative regulation of caspase activity | 6.151778e-5 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 6.445943e-5 |
GO:0050435 | beta-amyloid metabolic process | 6.977519e-5 |
GO:0006644 | phospholipid metabolic process | 7.558638e-5 |
GO:0019319 | hexose biosynthetic process | 7.903413e-5 |
GO:0060047 | heart contraction | 7.943164e-5 |
GO:0030299 | intestinal cholesterol absorption | 7.946839e-5 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 8.035358e-5 |
GO:0007217 | tachykinin receptor signaling pathway | 8.580197e-5 |
GO:0045471 | response to ethanol | 9.162180e-5 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 9.513123e-5 |
GO:0044330 | canonical Wnt receptor signaling pathway involved in positive regulation of wound healing | 1.002499e-4 |
GO:0044329 | canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion | 1.002499e-4 |
GO:0044328 | canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration | 1.002499e-4 |
GO:0016074 | snoRNA metabolic process | 1.016908e-4 |
GO:0071260 | cellular response to mechanical stimulus | 1.054024e-4 |
GO:0045351 | type I interferon biosynthetic process | 1.150711e-4 |
GO:0048935 | peripheral nervous system neuron development | 1.242747e-4 |
GO:0019637 | organophosphate metabolic process | 1.243255e-4 |
GO:0003015 | heart process | 1.314343e-4 |
GO:0006548 | histidine catabolic process | 1.538220e-4 |
GO:0035562 | negative regulation of chromatin binding | 1.590365e-4 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 1.590365e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.670337e-4 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.735875e-4 |
GO:0040012 | regulation of locomotion | 1.789742e-4 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 1.854933e-4 |
GO:0000045 | autophagic vacuole assembly | 1.902616e-4 |
GO:0035176 | social behavior | 1.991906e-4 |
GO:0090184 | positive regulation of kidney development | 2.340696e-4 |
GO:0006206 | pyrimidine base metabolic process | 2.364158e-4 |
GO:0009132 | nucleoside diphosphate metabolic process | 2.371178e-4 |
GO:0045875 | negative regulation of sister chromatid cohesion | 2.428738e-4 |
GO:0044255 | cellular lipid metabolic process | 2.614551e-4 |
GO:0071922 | regulation of cohesin localization to chromatin | 2.616013e-4 |
GO:0015876 | acetyl-CoA transport | 2.657544e-4 |
GO:0006547 | histidine metabolic process | 2.661761e-4 |
GO:0032507 | maintenance of protein location in cell | 2.826378e-4 |
GO:0009056 | catabolic process | 3.490946e-4 |
GO:0016180 | snRNA processing | 3.625218e-4 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 3.698135e-4 |
GO:0042938 | dipeptide transport | 3.698135e-4 |
GO:0045824 | negative regulation of innate immune response | 3.718470e-4 |
GO:0007608 | sensory perception of smell | 3.847616e-4 |
GO:0050795 | regulation of behavior | 3.873540e-4 |
GO:0070208 | protein heterotrimerization | 3.943903e-4 |
GO:0043555 | regulation of translation in response to stress | 4.059292e-4 |
GO:0034504 | protein localization to nucleus | 4.160207e-4 |
GO:0043410 | positive regulation of MAPKKK cascade | 4.221652e-4 |
GO:0014910 | regulation of smooth muscle cell migration | 4.241296e-4 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 4.434232e-4 |
GO:0048665 | neuron fate specification | 4.574158e-4 |
GO:0042335 | cuticle development | 4.610148e-4 |
GO:0018960 | 4-nitrophenol metabolic process | 4.610148e-4 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 4.610148e-4 |
GO:0046330 | positive regulation of JNK cascade | 4.679512e-4 |
GO:0031293 | membrane protein intracellular domain proteolysis | 4.702270e-4 |
GO:0034205 | beta-amyloid formation | 4.702270e-4 |
GO:0035814 | negative regulation of renal sodium excretion | 4.973809e-4 |
GO:0042414 | epinephrine metabolic process | 4.975798e-4 |
GO:0046364 | monosaccharide biosynthetic process | 5.019700e-4 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 5.019934e-4 |
GO:0044281 | small molecule metabolic process | 5.122105e-4 |
GO:0009231 | riboflavin biosynthetic process | 5.154306e-4 |
GO:0045343 | regulation of MHC class I biosynthetic process | 5.561144e-4 |
GO:0043558 | regulation of translational initiation in response to stress | 5.561144e-4 |
GO:0006972 | hyperosmotic response | 6.179158e-4 |
GO:0010459 | negative regulation of heart rate | 6.179158e-4 |
GO:0048520 | positive regulation of behavior | 6.536069e-4 |
GO:0002376 | immune system process | 6.539141e-4 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.723529e-4 |
GO:0051917 | regulation of fibrinolysis | 7.017428e-4 |
GO:0042727 | flavin-containing compound biosynthetic process | 7.217535e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 7.217535e-4 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 7.217535e-4 |
GO:0003326 | pancreatic A cell fate commitment | 7.217535e-4 |
GO:0050921 | positive regulation of chemotaxis | 7.296400e-4 |
GO:0042760 | very long-chain fatty acid catabolic process | 7.433261e-4 |
GO:0045884 | regulation of survival gene product expression | 7.496873e-4 |
GO:0034660 | ncRNA metabolic process | 7.670466e-4 |
GO:0001937 | negative regulation of endothelial cell proliferation | 7.767633e-4 |
GO:0007182 | common-partner SMAD protein phosphorylation | 7.854618e-4 |
GO:0009083 | branched chain family amino acid catabolic process | 7.875162e-4 |
GO:0046488 | phosphatidylinositol metabolic process | 8.028537e-4 |
GO:0006952 | defense response | 8.115079e-4 |
GO:0051918 | negative regulation of fibrinolysis | 8.210796e-4 |
GO:0006006 | glucose metabolic process | 8.220887e-4 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 8.361565e-4 |
GO:0042987 | amyloid precursor protein catabolic process | 8.405003e-4 |
GO:0021515 | cell differentiation in spinal cord | 8.462556e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 8.541185e-4 |
GO:0048844 | artery morphogenesis | 8.591596e-4 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 8.672191e-4 |
GO:0042089 | cytokine biosynthetic process | 8.815213e-4 |
GO:0006094 | gluconeogenesis | 9.057846e-4 |
GO:0000183 | chromatin silencing at rDNA | 9.245508e-4 |
GO:0042158 | lipoprotein biosynthetic process | 9.677004e-4 |
GO:0010812 | negative regulation of cell-substrate adhesion | 9.813992e-4 |
GO:0051383 | kinetochore organization | 9.883026e-4 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.008391e-3 |
GO:0009620 | response to fungus | 1.013818e-3 |
GO:0015887 | pantothenate transmembrane transport | 1.029783e-3 |
GO:0015878 | biotin transport | 1.029783e-3 |
GO:0009612 | response to mechanical stimulus | 1.050514e-3 |
GO:0034655 | nucleobase-containing compound catabolic process | 1.069071e-3 |
GO:0014888 | striated muscle adaptation | 1.069362e-3 |
GO:0008078 | mesodermal cell migration | 1.077528e-3 |
GO:0016073 | snRNA metabolic process | 1.081305e-3 |
GO:0090303 | positive regulation of wound healing | 1.082440e-3 |
GO:0021759 | globus pallidus development | 1.082440e-3 |
GO:0071345 | cellular response to cytokine stimulus | 1.089819e-3 |
GO:0007016 | cytoskeletal anchoring at plasma membrane | 1.103201e-3 |
GO:0042990 | regulation of transcription factor import into nucleus | 1.142857e-3 |
GO:0032386 | regulation of intracellular transport | 1.159209e-3 |
GO:0032879 | regulation of localization | 1.177262e-3 |
GO:0043589 | skin morphogenesis | 1.202611e-3 |
GO:0010033 | response to organic substance | 1.215191e-3 |
GO:0015893 | drug transport | 1.240176e-3 |
GO:0021522 | spinal cord motor neuron differentiation | 1.310091e-3 |
GO:0006518 | peptide metabolic process | 1.316477e-3 |
GO:0034505 | tooth mineralization | 1.320070e-3 |
GO:0070986 | left/right axis specification | 1.326508e-3 |
GO:0046341 | CDP-diacylglycerol metabolic process | 1.326508e-3 |
GO:0021629 | olfactory nerve structural organization | 1.326508e-3 |
GO:0043084 | penile erection | 1.345237e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 1.371127e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 1.371127e-3 |
GO:0016339 | calcium-dependent cell-cell adhesion | 1.374093e-3 |
GO:0016578 | histone deubiquitination | 1.431852e-3 |
GO:0007033 | vacuole organization | 1.461954e-3 |
GO:0007205 | activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 1.536878e-3 |
GO:0016236 | macroautophagy | 1.564183e-3 |
GO:0060221 | retinal rod cell differentiation | 1.577013e-3 |
GO:0071548 | response to dexamethasone stimulus | 1.629732e-3 |
GO:0001936 | regulation of endothelial cell proliferation | 1.650395e-3 |
GO:0021517 | ventral spinal cord development | 1.654526e-3 |
GO:0070164 | negative regulation of adiponectin secretion | 1.737239e-3 |
GO:0071217 | cellular response to external biotic stimulus | 1.737239e-3 |
GO:0034474 | U2 snRNA 3'-end processing | 1.737239e-3 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 1.737239e-3 |
GO:0051382 | kinetochore assembly | 1.745687e-3 |
GO:0045345 | positive regulation of MHC class I biosynthetic process | 1.745687e-3 |
GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis | 1.748750e-3 |
GO:0060784 | regulation of cell proliferation involved in tissue homeostasis | 1.748750e-3 |
GO:0060517 | epithelial cell proliferation involved in prostatic bud elongation | 1.748750e-3 |
GO:0035622 | intrahepatic bile duct development | 1.748750e-3 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 1.774137e-3 |
GO:0019538 | protein metabolic process | 1.813867e-3 |
GO:0006586 | indolalkylamine metabolic process | 1.859658e-3 |
GO:0031960 | response to corticosteroid stimulus | 1.864572e-3 |
GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1.895236e-3 |
GO:0006568 | tryptophan metabolic process | 1.897379e-3 |
GO:0048635 | negative regulation of muscle organ development | 1.900799e-3 |
GO:0045885 | positive regulation of survival gene product expression | 1.926224e-3 |
GO:0051542 | elastin biosynthetic process | 1.933382e-3 |
GO:0048553 | negative regulation of metalloenzyme activity | 1.933382e-3 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.946190e-3 |
GO:0032103 | positive regulation of response to external stimulus | 1.952691e-3 |
GO:0006399 | tRNA metabolic process | 1.971116e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 2.024126e-3 |
GO:0010466 | negative regulation of peptidase activity | 2.038269e-3 |
GO:0071214 | cellular response to abiotic stimulus | 2.040605e-3 |
GO:0009081 | branched chain family amino acid metabolic process | 2.048944e-3 |
GO:0042375 | quinone cofactor metabolic process | 2.075863e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 2.086752e-3 |
GO:0009589 | detection of UV | 2.086752e-3 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 2.086752e-3 |
GO:0043043 | peptide biosynthetic process | 2.155787e-3 |
GO:0060973 | cell migration involved in heart development | 2.156707e-3 |
GO:0006970 | response to osmotic stress | 2.158447e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.165036e-3 |
GO:0009112 | nucleobase metabolic process | 2.181797e-3 |
GO:0034284 | response to monosaccharide stimulus | 2.186103e-3 |
GO:0015816 | glycine transport | 2.195913e-3 |
GO:0044282 | small molecule catabolic process | 2.204378e-3 |
GO:0034502 | protein localization to chromosome | 2.222962e-3 |
GO:0042982 | amyloid precursor protein metabolic process | 2.357689e-3 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.385733e-3 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 2.385733e-3 |
GO:0031529 | ruffle organization | 2.385971e-3 |
GO:0006213 | pyrimidine nucleoside metabolic process | 2.390360e-3 |
GO:0070613 | regulation of protein processing | 2.394402e-3 |
GO:0006955 | immune response | 2.415201e-3 |
GO:0042493 | response to drug | 2.431541e-3 |
GO:0006002 | fructose 6-phosphate metabolic process | 2.453212e-3 |
GO:0060137 | maternal process involved in parturition | 2.466936e-3 |
GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure | 2.525808e-3 |
GO:0046483 | heterocycle metabolic process | 2.575919e-3 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 2.597315e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 2.608895e-3 |
GO:0035601 | protein deacylation | 2.614846e-3 |
GO:0006497 | protein lipidation | 2.666387e-3 |
GO:0071320 | cellular response to cAMP | 2.717976e-3 |
GO:0045087 | innate immune response | 2.740794e-3 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 2.742174e-3 |
GO:0042107 | cytokine metabolic process | 2.821097e-3 |
GO:0002573 | myeloid leukocyte differentiation | 2.850632e-3 |
GO:0007620 | copulation | 2.874683e-3 |
GO:0044057 | regulation of system process | 2.904432e-3 |
GO:0072034 | renal vesicle induction | 2.951352e-3 |
GO:0051179 | localization | 2.992635e-3 |
GO:0042696 | menarche | 3.038532e-3 |
GO:0070534 | protein K63-linked ubiquitination | 3.042957e-3 |
GO:0002286 | T cell activation involved in immune response | 3.085605e-3 |
GO:0006476 | protein deacetylation | 3.103661e-3 |
GO:0051531 | NFAT protein import into nucleus | 3.227576e-3 |
GO:0045426 | quinone cofactor biosynthetic process | 3.254068e-3 |
GO:0061103 | carotid body glomus cell differentiation | 3.267483e-3 |
GO:0061104 | adrenal chromaffin cell differentiation | 3.267483e-3 |
GO:0003359 | noradrenergic neuron fate commitment | 3.267483e-3 |
GO:0061102 | stomach neuroendocrine cell differentiation | 3.267483e-3 |
GO:0071259 | cellular response to magnetism | 3.267483e-3 |
GO:0061100 | lung neuroendocrine cell differentiation | 3.267483e-3 |
GO:0007400 | neuroblast fate determination | 3.267483e-3 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 3.267483e-3 |
GO:0051668 | localization within membrane | 3.293285e-3 |
GO:0030307 | positive regulation of cell growth | 3.296155e-3 |
GO:0009746 | response to hexose stimulus | 3.300239e-3 |
GO:0051705 | behavioral interaction between organisms | 3.384505e-3 |
GO:0032863 | activation of Rac GTPase activity | 3.503687e-3 |
GO:0051651 | maintenance of location in cell | 3.515074e-3 |
GO:0043628 | ncRNA 3'-end processing | 3.525952e-3 |
GO:0042628 | mating plug formation | 3.525952e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 3.534369e-3 |
GO:0048514 | blood vessel morphogenesis | 3.614547e-3 |
GO:0044111 | development involved in symbiotic interaction | 3.655773e-3 |
GO:0035021 | negative regulation of Rac protein signal transduction | 3.655773e-3 |
GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 3.655773e-3 |
GO:0006172 | ADP biosynthetic process | 3.655773e-3 |
GO:0019089 | transmission of virus | 3.655773e-3 |
GO:0001959 | regulation of cytokine-mediated signaling pathway | 3.681366e-3 |
GO:0033365 | protein localization to organelle | 3.693913e-3 |
GO:0032101 | regulation of response to external stimulus | 3.762009e-3 |
GO:0060840 | artery development | 3.770903e-3 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 3.824377e-3 |
GO:0006195 | purine nucleotide catabolic process | 4.011550e-3 |
GO:0006629 | lipid metabolic process | 4.017710e-3 |
GO:0045185 | maintenance of protein location | 4.058071e-3 |
GO:0071474 | cellular hyperosmotic response | 4.173506e-3 |
GO:0071394 | cellular response to testosterone stimulus | 4.173506e-3 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 4.184729e-3 |
GO:0006506 | GPI anchor biosynthetic process | 4.192792e-3 |
GO:0006457 | protein folding | 4.228437e-3 |
GO:0009743 | response to carbohydrate stimulus | 4.270297e-3 |
GO:0097107 | postsynaptic density assembly | 4.272877e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 4.272877e-3 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 4.272877e-3 |
GO:0008063 | Toll signaling pathway | 4.272877e-3 |
GO:0010273 | detoxification of copper ion | 4.272877e-3 |
GO:0019442 | tryptophan catabolic process to acetyl-CoA | 4.272877e-3 |
GO:0048193 | Golgi vesicle transport | 4.314285e-3 |
GO:0050920 | regulation of chemotaxis | 4.317935e-3 |
GO:0007162 | negative regulation of cell adhesion | 4.401961e-3 |
GO:0006578 | betaine biosynthetic process | 4.402067e-3 |
GO:0072523 | purine-containing compound catabolic process | 4.404312e-3 |
GO:0002070 | epithelial cell maturation | 4.411867e-3 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 4.485949e-3 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 4.485949e-3 |
GO:0044241 | lipid digestion | 4.540129e-3 |
GO:0071168 | protein localization to chromatin | 4.553562e-3 |
GO:0032811 | negative regulation of epinephrine secretion | 4.553562e-3 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 4.574959e-3 |
GO:0003008 | system process | 4.603559e-3 |
GO:0030449 | regulation of complement activation | 4.628954e-3 |
GO:0032273 | positive regulation of protein polymerization | 4.646131e-3 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 4.682036e-3 |
GO:0060759 | regulation of response to cytokine stimulus | 4.710416e-3 |
GO:0055003 | cardiac myofibril assembly | 4.720703e-3 |
GO:0009166 | nucleotide catabolic process | 4.822363e-3 |
GO:0001878 | response to yeast | 4.920921e-3 |
GO:0009310 | amine catabolic process | 4.933384e-3 |
GO:0009628 | response to abiotic stimulus | 4.952979e-3 |
GO:0032964 | collagen biosynthetic process | 4.996250e-3 |
GO:0007158 | neuron cell-cell adhesion | 5.025749e-3 |
GO:0007606 | sensory perception of chemical stimulus | 5.042670e-3 |
GO:0060350 | endochondral bone morphogenesis | 5.056142e-3 |
GO:0045843 | negative regulation of striated muscle tissue development | 5.179824e-3 |
GO:0046822 | regulation of nucleocytoplasmic transport | 5.211348e-3 |
GO:2000821 | regulation of grooming behavior | 5.256648e-3 |
GO:0006725 | cellular aromatic compound metabolic process | 5.271509e-3 |
GO:0016310 | phosphorylation | 5.316392e-3 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 5.367957e-3 |
GO:0009992 | cellular water homeostasis | 5.367957e-3 |
GO:0006685 | sphingomyelin catabolic process | 5.367957e-3 |
GO:0051235 | maintenance of location | 5.466149e-3 |
GO:0006855 | drug transmembrane transport | 5.605603e-3 |
GO:0060729 | intestinal epithelial structure maintenance | 5.607972e-3 |
GO:0045732 | positive regulation of protein catabolic process | 5.632551e-3 |
GO:0048102 | autophagic cell death | 5.787045e-3 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 5.787045e-3 |
GO:0060730 | regulation of intestinal epithelial structure maintenance | 5.823478e-3 |
GO:0002082 | regulation of oxidative phosphorylation | 5.823478e-3 |
GO:0035883 | enteroendocrine cell differentiation | 5.823478e-3 |
GO:0005996 | monosaccharide metabolic process | 5.851322e-3 |
GO:0042796 | snRNA transcription from RNA polymerase III promoter | 5.968354e-3 |
GO:0051545 | negative regulation of elastin biosynthetic process | 5.968354e-3 |
GO:0042795 | snRNA transcription from RNA polymerase II promoter | 5.968354e-3 |
GO:0006709 | progesterone catabolic process | 5.968354e-3 |
GO:0030316 | osteoclast differentiation | 5.983388e-3 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 6.060125e-3 |
GO:0060737 | prostate gland morphogenetic growth | 6.077489e-3 |
GO:0043501 | skeletal muscle adaptation | 6.092871e-3 |
GO:0021953 | central nervous system neuron differentiation | 6.150000e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 6.161238e-3 |
GO:0001568 | blood vessel development | 6.205652e-3 |
GO:0002035 | brain renin-angiotensin system | 6.269100e-3 |
GO:0019221 | cytokine-mediated signaling pathway | 6.284049e-3 |
GO:0032331 | negative regulation of chondrocyte differentiation | 6.316827e-3 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 6.433154e-3 |
GO:0009749 | response to glucose stimulus | 6.441081e-3 |
GO:0021553 | olfactory nerve development | 6.747259e-3 |
GO:0009072 | aromatic amino acid family metabolic process | 6.754382e-3 |
GO:0010810 | regulation of cell-substrate adhesion | 6.755177e-3 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 6.757981e-3 |
GO:0019100 | male germ-line sex determination | 6.834785e-3 |
GO:0019318 | hexose metabolic process | 6.974331e-3 |
GO:0006360 | transcription from RNA polymerase I promoter | 7.045595e-3 |
GO:0019098 | reproductive behavior | 7.094593e-3 |
GO:0050930 | induction of positive chemotaxis | 7.280677e-3 |
GO:0048241 | epinephrine transport | 7.325354e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 7.461248e-3 |
GO:0010226 | response to lithium ion | 7.547432e-3 |
GO:0034516 | response to vitamin B6 | 7.548353e-3 |
GO:0043420 | anthranilate metabolic process | 7.548353e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 7.548353e-3 |
GO:0033602 | negative regulation of dopamine secretion | 7.581125e-3 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 7.714868e-3 |
GO:0032298 | positive regulation of DNA-dependent DNA replication initiation | 7.714868e-3 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 7.714868e-3 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 7.714868e-3 |
GO:0014005 | microglia development | 7.714868e-3 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 7.714868e-3 |
GO:0031116 | positive regulation of microtubule polymerization | 7.764862e-3 |
GO:0010040 | response to iron(II) ion | 7.895735e-3 |
GO:0072527 | pyrimidine-containing compound metabolic process | 7.966067e-3 |
GO:0002521 | leukocyte differentiation | 8.066504e-3 |
GO:0010038 | response to metal ion | 8.104808e-3 |
GO:0046854 | phosphatidylinositol phosphorylation | 8.247648e-3 |
GO:0003415 | chondrocyte hypertrophy | 8.249886e-3 |
GO:0033157 | regulation of intracellular protein transport | 8.273732e-3 |
GO:0051414 | response to cortisol stimulus | 8.275394e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 8.328968e-3 |
GO:0042891 | antibiotic transport | 8.476217e-3 |
GO:0071872 | cellular response to epinephrine stimulus | 8.476217e-3 |
GO:0032534 | regulation of microvillus assembly | 8.476217e-3 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 8.492230e-3 |
GO:0015758 | glucose transport | 8.579538e-3 |
GO:0050804 | regulation of synaptic transmission | 8.616019e-3 |
GO:0046165 | alcohol biosynthetic process | 8.691410e-3 |
GO:0014911 | positive regulation of smooth muscle cell migration | 8.754794e-3 |
GO:0043550 | regulation of lipid kinase activity | 8.837656e-3 |
GO:0015870 | acetylcholine transport | 8.904457e-3 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 8.904457e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 8.981198e-3 |
GO:0045661 | regulation of myoblast differentiation | 9.035990e-3 |
GO:0006661 | phosphatidylinositol biosynthetic process | 9.045052e-3 |
GO:0071625 | vocalization behavior | 9.075004e-3 |
GO:0051969 | regulation of transmission of nerve impulse | 9.086980e-3 |
GO:0051051 | negative regulation of transport | 9.320222e-3 |
GO:0046164 | alcohol catabolic process | 9.437908e-3 |
GO:0009396 | folic acid-containing compound biosynthetic process | 9.466503e-3 |
GO:0006744 | ubiquinone biosynthetic process | 9.466503e-3 |
GO:0070542 | response to fatty acid | 9.648051e-3 |
GO:0016049 | cell growth | 9.691266e-3 |
GO:0006622 | protein targeting to lysosome | 9.835212e-3 |
GO:0001306 | age-dependent response to oxidative stress | 9.869112e-3 |
GO:0070849 | response to epidermal growth factor stimulus | 9.989347e-3 |
GO:2000822 | regulation of behavioral fear response | 9.989556e-3 |
GO:0035881 | amacrine cell differentiation | 1.003343e-2 |
GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 1.003343e-2 |
GO:0002544 | chronic inflammatory response | 1.007502e-2 |
GO:0042220 | response to cocaine | 1.022077e-2 |
GO:0032891 | negative regulation of organic acid transport | 1.031110e-2 |
GO:0060547 | negative regulation of necrotic cell death | 1.036745e-2 |
GO:0006007 | glucose catabolic process | 1.037118e-2 |
GO:0051956 | negative regulation of amino acid transport | 1.039273e-2 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 1.043662e-2 |
GO:0046654 | tetrahydrofolate biosynthetic process | 1.043662e-2 |
GO:0048588 | developmental cell growth | 1.056570e-2 |
GO:0051170 | nuclear import | 1.062706e-2 |
GO:0050916 | sensory perception of sweet taste | 1.063697e-2 |
GO:0060163 | subpallium neuron fate commitment | 1.063697e-2 |
GO:0019805 | quinolinate biosynthetic process | 1.063697e-2 |
GO:0002071 | glandular epithelial cell maturation | 1.063697e-2 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.072970e-2 |
GO:0034097 | response to cytokine stimulus | 1.081982e-2 |
GO:0043500 | muscle adaptation | 1.090155e-2 |
GO:0060180 | female mating behavior | 1.093384e-2 |
GO:0044283 | small molecule biosynthetic process | 1.110587e-2 |
GO:0009755 | hormone-mediated signaling pathway | 1.111428e-2 |
GO:0009261 | ribonucleotide catabolic process | 1.118845e-2 |
GO:0009309 | amine biosynthetic process | 1.126823e-2 |
GO:0090068 | positive regulation of cell cycle process | 1.130202e-2 |
GO:0055002 | striated muscle cell development | 1.133026e-2 |
GO:0008156 | negative regulation of DNA replication | 1.133558e-2 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.149716e-2 |
GO:0030277 | maintenance of gastrointestinal epithelium | 1.170811e-2 |
GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 1.170811e-2 |
GO:0006882 | cellular zinc ion homeostasis | 1.186709e-2 |
GO:0031272 | regulation of pseudopodium assembly | 1.187458e-2 |
GO:0006950 | response to stress | 1.196147e-2 |
GO:0042402 | cellular biogenic amine catabolic process | 1.199413e-2 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.205741e-2 |
GO:0035722 | interleukin-12-mediated signaling pathway | 1.205741e-2 |
GO:0060516 | primary prostatic bud elongation | 1.205741e-2 |
GO:0015874 | norepinephrine transport | 1.205741e-2 |
GO:0010815 | bradykinin catabolic process | 1.205741e-2 |
GO:0031032 | actomyosin structure organization | 1.206184e-2 |
GO:0042100 | B cell proliferation | 1.216415e-2 |
GO:0045663 | positive regulation of myoblast differentiation | 1.216937e-2 |
GO:0055006 | cardiac cell development | 1.220271e-2 |
GO:0007184 | SMAD protein import into nucleus | 1.226104e-2 |
GO:0008645 | hexose transport | 1.230029e-2 |
GO:0043279 | response to alkaloid | 1.230763e-2 |
GO:0000038 | very long-chain fatty acid metabolic process | 1.240809e-2 |
GO:0002252 | immune effector process | 1.242409e-2 |
GO:0009259 | ribonucleotide metabolic process | 1.243852e-2 |
GO:0010811 | positive regulation of cell-substrate adhesion | 1.259155e-2 |
GO:0051704 | multi-organism process | 1.262732e-2 |
GO:0010232 | vascular transport | 1.269789e-2 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.271221e-2 |
GO:0045575 | basophil activation | 1.272868e-2 |
GO:0015868 | purine ribonucleotide transport | 1.275575e-2 |
GO:0070933 | histone H4 deacetylation | 1.275575e-2 |
GO:0007567 | parturition | 1.275575e-2 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.276476e-2 |
GO:0003094 | glomerular filtration | 1.276476e-2 |
GO:0006606 | protein import into nucleus | 1.287851e-2 |
GO:0001958 | endochondral ossification | 1.291576e-2 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 1.299062e-2 |
GO:0030097 | hemopoiesis | 1.300712e-2 |
GO:0031113 | regulation of microtubule polymerization | 1.306241e-2 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 1.313001e-2 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 1.313001e-2 |
GO:0006570 | tyrosine metabolic process | 1.313001e-2 |
GO:0090162 | establishment of epithelial cell polarity | 1.319960e-2 |
GO:0035767 | endothelial cell chemotaxis | 1.324080e-2 |
GO:0045924 | regulation of female receptivity | 1.324080e-2 |
GO:0034770 | histone H4-K20 methylation | 1.348477e-2 |
GO:0006954 | inflammatory response | 1.355533e-2 |
GO:0050892 | intestinal absorption | 1.369370e-2 |
GO:0007618 | mating | 1.371662e-2 |
GO:0045088 | regulation of innate immune response | 1.374701e-2 |
GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.390980e-2 |
GO:0009116 | nucleoside metabolic process | 1.414435e-2 |
GO:0019320 | hexose catabolic process | 1.429153e-2 |
GO:0030239 | myofibril assembly | 1.429447e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.432309e-2 |
GO:0042780 | tRNA 3'-end processing | 1.443706e-2 |
GO:0010041 | response to iron(III) ion | 1.443706e-2 |
GO:0045022 | early endosome to late endosome transport | 1.449984e-2 |
GO:0014912 | negative regulation of smooth muscle cell migration | 1.454525e-2 |
GO:0008015 | blood circulation | 1.459718e-2 |
GO:0055013 | cardiac muscle cell development | 1.460546e-2 |
GO:2000136 | regulation of cell proliferation involved in heart morphogenesis | 1.472271e-2 |
GO:0009395 | phospholipid catabolic process | 1.477426e-2 |